Pentamethonium bromide

This classification denotes a nicotinic antagonist with the molecular formula C11H28N2.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0UX03A6JJC, chemically known as 1,5-pentanediaminium, n,n,n,n,n,n-hexamethyl-, dibromide (9ci) but more generally known as pentamethonium bromide, which bears US NIH Compound Identifier 10919. European Medicines Agency schedules Pentamethonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09681MIG. The term PENTAMETHONIUM BROMIDE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule pentamethonium bromide under HS 29239000 and SITC 51481. As of Q4 2014, PENTAMETHONIUM BROMIDE remains US FDA's Preferred Term for this commodity. Pentamethonium bromide bears US NLM identifiers UMLS ID C0304528 and NCI Concept Code C80532. SMILES: C[N+](C)(C)CCCCC[N+](C)(C)C.[BR-].[BR-].